newsfilter
← Latest News
Business Wire·

Harwood Feffer LLP Announces Investigation of Clinical Data, Inc.

NEW YORK--(BUSINESS WIRE)--Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Clinical Data, Inc. (NASDAQ - CLDA) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell CLDA to Forest Laboratories Inc. (NYSE – FRX) in a transaction valued at approximately $1 billion.